Physician

Alexandre Hageboutros, MD

According to 2025 Medicare claims, Alexandre Hageboutros, MD (NPI: 1598874042) practices hematology/oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CMC DEPARTMENT OF MEDICINE GROUP PA (NPI: 1588796882; TIN: 223266219) and primary practice location at 08043-4637.

Hageboutros' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 669 HCPCS/CPT codes, and received $47,395 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 238 prescription claims across 71 beneficiaries totaling $731,610 in drug costs, led by Tabrecta (Capmatinib Hydrochloride). DME data shows 11 claims. Open Payments data shows 1 records totaling $400. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $67,094 to $47,395. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $146,024 and ending at $731,610. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $32,557 to $105.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	325	1,092	$67,094
2016	347	1,225	$96,138
2017	285	1,362	$125,003
2018	297	1,198	$102,495
2019	279	1,180	$98,132
2020	251	677	$46,391
2021	238	542	$43,402
2022	223	594	$47,863
2023	217	577	$46,971
2024	199	669	$47,395

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	116	486	$146,024
2016	97	382	$468,616
2017	79	270	$217,086
2018	78	299	$579,483
2019	118	479	$864,423
2020	71	278	$603,747
2021	52	146	$204,748
2022	55	180	$603,774
2023	53	160	$189,324
2024	71	238	$731,610

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	103	974	$53,320
2016	91	832	$25,375
2017	86	516	$17,908
2018	49	274	$12,914
2019	44	457	$24,651
2020	N/R	348	$25,161
2021	N/R	79	$1,660
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$105

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	22	22	$162
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	15	15	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	152	413	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	71	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	63	105	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tabrecta	Capmatinib Hydrochloride	11	308	$245,983
Zenpep	Lipase/Protease/Amylase	19	556	$15,382
Eliquis	Apixaban	14	480	$10,199
Ondansetron Odt	Ondansetron	29	243	$270
Prochlorperazine Maleate	Prochlorperazine Maleate	29	216	$223

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1038	Transport chair, adult size, patient weight capacity up to and including 300 pounds	Y	N/R	11	$105

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$400	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexandre Hageboutros, MD?

Tedicare shows public-source Medicare data for Alexandre Hageboutros, MD (NPI 1598874042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandre Hageboutros, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandre Hageboutros, MD?

Alexandre Hageboutros, MD is linked to CMC DEPARTMENT OF MEDICINE GROUP PA (billing NPI 1588796882) in the available physician profile data.

Does Alexandre Hageboutros, MD have Open Payments data?

Alexandre Hageboutros, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.